Failed back surgery syndrome (FBSS) is persistent or recurrent spinal pain that continues after spine surgery that failed to achieve its intended outcome. Up to 40% of back surgeries do not achieve the desired outcome; revision rates can exceed 20% within ten years. FBSS is not a dead end — targeted evaluation and regenerative options produce measurable relief for most patients.

If you have had a spinal procedure and still live with significant back or leg pain, you are not alone and you are not out of options. FBSS affects hundreds of thousands of patients every year. Understanding why surgery failed is the first step toward a recovery path that does not involve another operation. ValorSpine specializes in non-surgical spine treatment for patients who have already been through the surgical route and are looking for a different approach.

This page defines FBSS precisely, explains the most common failure mechanisms, describes the diagnostic workup used to identify what went wrong, and outlines the regenerative and non-surgical treatment options — including intra-annular fibrin injection — that have demonstrated positive outcomes in this patient population. For a broader overview, see our complete guide to failed back surgery syndrome treatment.

Definition: What Is Failed Back Surgery Syndrome?

Failed back surgery syndrome is a clinical term describing the condition of a patient who undergoes spine surgery with the expectation of pain relief or functional improvement and does not achieve that result — or achieves it only temporarily before symptoms recur. The word “syndrome” reflects the reality that FBSS is not a single disease but a collection of overlapping failure modes that share one common endpoint: the patient still hurts after surgery.

The term is sometimes criticized because it places the label of failure on the patient rather than on the procedure or the decision to operate. In practice, FBSS almost always reflects one of several well-characterized failure mechanisms, all of which are identifiable with modern imaging and diagnostic tools. Identifying the specific mechanism is essential because the correct next step depends entirely on which failure mode is present.

Roughly 80% of people experience significant back pain at some point in their lifetime. Of those who proceed to surgery, roughly 40% do not achieve the desired outcome — meaning FBSS represents a substantial proportion of the chronic spine pain population.

Why It Happens: Common Causes of FBSS

FBSS is not random. Each case traces back to one or more identifiable mechanisms. The four most common are wrong patient selection, adjacent segment disease, epidural fibrosis (scar tissue), and recurrent disc herniation. Hardware failure and post-surgical infection account for a smaller but significant subset.

Wrong Patient Selection and Missed Diagnosis

The most preventable cause of FBSS is operating on the wrong pain generator. If the primary source of a patient’s pain is an annular tear at L4-L5 but the surgeon fuses L5-S1 based on imaging that shows degeneration at both levels, the surgery addresses the wrong target. Post-operative symptoms persist not because the surgery failed technically but because it succeeded at the wrong level. Careful pre-operative diagnostic workup — including targeted injections to identify the true pain generator — is the only reliable way to avoid this outcome.

Adjacent Segment Disease

Spinal fusion works by eliminating motion at one or more disc levels. The mechanical consequence is that the discs immediately above and below the fused segment must absorb all the motion that the fused levels no longer provide. Over time, this accelerated mechanical loading breaks down the adjacent disc’s annular fibers, leading to new herniations, new annular tears, and new pain — sometimes indistinguishable from the original complaint. Adjacent segment disease is the reason revision surgery rates can exceed 20% within 10 years of the original procedure. Learn more about how adjacent segment disease is treated without repeat fusion in our adjacent segment disease fibrin case study.

Epidural Fibrosis

Any surgical entry into the spinal canal triggers a healing response. For some patients, that healing response produces excessive scar tissue (epidural fibrosis) that physically wraps around nerve roots and tethers them. On post-contrast MRI, scar tissue enhances with gadolinium in a pattern that distinguishes it from recurrent disc herniation — a critical distinction because the two conditions require different treatments. Epidural fibrosis tends to produce persistent radicular symptoms (leg pain, numbness, weakness) rather than axial back pain alone.

Recurrent Disc Herniation

Discectomy removes herniated nucleus material but does not repair the annular defect through which that material escaped. An unrepaired annular tear is a structural vulnerability. Re-herniation through the same defect occurs in a meaningful percentage of post-discectomy patients, reproducing the original radiculopathy. Annular tear repair via fibrin disc treatment addresses this vulnerability directly by sealing the defect rather than simply removing material again. See how this approach compares to repeat surgery in our fibrin vs. fusion FAQ.

Why It Matters: The Real-World Burden of FBSS

FBSS carries significant consequences beyond persistent pain. Patients with FBSS have higher rates of opioid dependence than the general chronic pain population, higher rates of depression and anxiety, and substantially reduced functional capacity and quality of life. The economic burden — lost wages, ongoing medical costs, disability claims — is considerable.

Perhaps more importantly, FBSS creates a psychological barrier. Many patients believe that because surgery did not help, nothing will. This belief leads to under-treatment and resignation to a chronic pain state that is, in many cases, addressable. The clinical evidence does not support the conclusion that FBSS is a permanent condition. It supports the conclusion that FBSS requires a more precise diagnosis of the failure mode before the next intervention is selected.

For patients who have already had one or more spine surgeries, the question is not whether to pursue non-surgical care — it is which specific structural problem remains and whether a targeted regenerative or interventional approach can address it. Our overview of non-surgical spine treatments ranked by evidence provides a framework for evaluating the options systematically.

Key Components: Workup and What Options Remain

Diagnostic Workup for FBSS

The evaluation of a patient with FBSS begins with a detailed history focused on the timeline of symptoms relative to surgery. Three patterns are clinically meaningful:

• Never improved: suggests the surgery addressed the wrong pain generator or was technically incomplete
• Improved then relapsed within weeks: suggests recurrent herniation or hardware complication
• Improved for months or years then relapsed: suggests adjacent segment disease or delayed scar formation

Post-operative MRI with gadolinium contrast is the foundational imaging study. CT is added when hardware integrity or bony fusion status is uncertain. Flexion-extension X-rays identify instability at adjacent segments. Targeted diagnostic injections (selective nerve root blocks, medial branch blocks) help isolate the specific pain generator when imaging is ambiguous.

Regenerative Options: Intra-Annular Fibrin Injection

For patients whose FBSS traces to untreated or recurrent annular tears — whether at the original surgical level, at an adjacent segment, or at a level that was simply never addressed — intra-annular fibrin injection (biologic disc repair) is a category of treatment with a growing evidence base in this population specifically.

Published clinical data show that 80% of failed-back-surgery patients reported positive outcomes following fibrin injection. VAS pain scores in fibrin studies dropped from 72.4 mm at baseline to 33.0 mm at 104 weeks — a sustained reduction maintained at two years. Patient satisfaction at two or more year follow-up was 70%. These figures are particularly notable because FBSS patients represent a high-complexity, treatment-resistant group for whom standard interventions have already proven insufficient.

The mechanism is structural: fibrin injected into the annular defect seals the tear, reduces mechanical instability, and allows the disc’s native healing biology to operate in a protected environment. Unlike revision surgery, the procedure does not further destabilize the spine, does not require general anesthesia, and does not carry the tissue-damage costs of an additional surgical approach.

For a comparison of how this approach differs from repeat fusion, see our spinal fusion alternatives guide. For patients who want to know whether they were candidates for non-surgical treatment before their first surgery, our article on signs you can avoid spine surgery is a useful reference.

Related Terms

• Post-laminectomy syndrome — an older term for FBSS, used specifically after laminectomy procedures; largely replaced by FBSS in current clinical literature
• Adjacent segment disease (ASD) — degeneration at spinal levels neighboring a previous fusion; a primary cause and a distinct clinical entity within the FBSS umbrella
• Epidural fibrosis — excessive post-surgical scar tissue encasing nerve roots; a major driver of persistent radiculopathy in FBSS
• Annular tear — a fissure or disruption in the outer wall (annulus fibrosus) of an intervertebral disc; both a cause of initial surgery and a common residual finding after surgery that did not address the annulus directly
• Pseudarthrosis — failure of a spinal fusion to achieve solid bony union across the intended segment; a hardware-related cause of FBSS
• Biologic disc repair — the use of regenerative biological materials (such as fibrin) to restore structural integrity to a damaged disc; an emerging non-surgical option for FBSS patients

Common Misconceptions About FBSS

Misconception: “Failed back surgery syndrome” means the surgeon made an error.
Reality: FBSS describes a clinical outcome, not surgical negligence. The most common cause is that the operated level was not the primary pain generator — a diagnostic limitation, not a technical failure. Many FBSS cases involve technically successful surgeries that simply addressed the wrong target.

Misconception: Once you have FBSS, you have to live with chronic pain.
Reality: The published data on intra-annular fibrin injection show 80% positive outcomes in this population specifically. The key is identifying the specific failure mode. FBSS is a heterogeneous condition, and the appropriate next step depends entirely on which mechanism is driving persistent symptoms.

Misconception: The only option after failed back surgery is another surgery.
Reality: Revision surgery carries higher complication rates, longer recovery, and lower success rates than primary surgery. Non-surgical pathways — including biologic disc repair — are evidence-supported alternatives that do not require another surgical approach. Our non-surgical spine recovery case study illustrates what recovery looks like when a structural diagnosis guides treatment selection.

Misconception: Back pain after surgery always means the hardware or fusion failed.
Reality: Hardware failure and pseudarthrosis account for only a subset of FBSS cases. The majority involve nerve-related, disc-related, or scar-related mechanisms that imaging and targeted injections can identify without hardware involvement.

Frequently Asked Questions About Failed Back Surgery Syndrome

How is failed back surgery syndrome diagnosed?

Diagnosis begins with a detailed history of symptoms before surgery, immediately after surgery, and at the time of current evaluation. The timeline tells the clinician which failure mechanism is most likely. Post-operative MRI with gadolinium contrast is the primary imaging study — gadolinium distinguishes epidural scar tissue (which enhances with contrast) from recurrent disc herniation (which does not). CT is added when bony fusion status or hardware integrity is in question. Targeted diagnostic injections — selective nerve root blocks, medial branch blocks, or provocative discography — are used when imaging alone does not identify the pain generator. The goal of the workup is not to confirm that FBSS exists but to identify the specific structural mechanism driving ongoing pain, because that mechanism determines which treatment is appropriate.

Can failed back surgery syndrome be treated without another operation?

For a substantial proportion of FBSS patients, yes. The treatment-eligibility question depends on the failure mechanism. Patients whose persistent pain traces to untreated or recurrent annular tears, adjacent segment disc pathology, or a missed pain generator that was not addressed by the original surgery are candidates for non-surgical interventions including intra-annular fibrin injection (biologic disc repair). Clinical studies in the FBSS population specifically report 80% positive outcomes and sustained VAS pain score reductions (from 72.4 mm to 33.0 mm at two years) with fibrin injection. Patients whose pain is driven by hardware failure or pseudarthrosis typically require surgical evaluation before regenerative options are appropriate. The distinction between these groups is established through the diagnostic workup described above.

What is the difference between FBSS and adjacent segment disease?

Adjacent segment disease (ASD) is one cause of FBSS, not a synonym for it. FBSS is the broader clinical term describing persistent or recurrent pain after any spinal surgery that failed to achieve the intended outcome. ASD specifically refers to accelerated degeneration at disc levels adjacent to a prior fusion, caused by the mechanical load transfer that results when a segment is rendered immobile. A patient develops ASD over months or years after fusion, and the new pain generator is the adjacent disc rather than the fused level. ASD is a common explanation for the “late relapse” pattern in FBSS — patients who improved after surgery and then deteriorated again one to five years later. Treatment of ASD-driven FBSS targets the adjacent level with biologic options rather than extending the fusion further.

What percentage of back surgeries result in FBSS?

Roughly 40% of back surgeries do not achieve the patient’s desired outcome. This figure encompasses a range of surgical types and patient populations, and the rate varies by procedure: simple discectomy has lower failure rates than multi-level fusion. Revision surgery rates after spinal fusion can exceed 20% within 10 years, indicating that a substantial fraction of the surgical population requires a second intervention. These statistics do not mean surgery should never be considered — they mean that patient selection, diagnostic precision, and the availability of evidence-supported alternatives deserve careful weight in the pre-surgical conversation.

Is intra-annular fibrin injection appropriate for all FBSS patients?

No. Intra-annular fibrin injection is specifically appropriate when the failure mechanism involves an annular defect — either at the original surgical level (recurrent herniation, unrepaired annular tear post-discectomy) or at an adjacent segment (ASD-driven disc pathology). Patients with FBSS caused primarily by epidural fibrosis, hardware failure, pseudarthrosis, or arachnoiditis require different treatment pathways. Appropriate candidate selection depends on the diagnostic workup: post-operative MRI, targeted injections, and clinical history. A consultation with a specialist experienced in the FBSS population is the appropriate starting point for determining whether fibrin disc treatment is indicated.

Sources and Further Reading

1. Hussain A, et al. “Failed Back Surgery Syndrome: Etiology and Current Management.” Neurochirurgie. 2021.
2. Chan CW, Peng P. “Failed Back Surgery Syndrome.” Pain Medicine. 2011;12(4):577–606.
3. Schofferman J, Reynolds J, et al. “Failed Back Surgery: Etiology and Diagnostic Evaluation.” Spine Journal. 2003.
4. Baber Z, Bhatt DL. “Fibrin Sealant Applications in Spine Surgery.” Journal of Spinal Disorders and Techniques. 2017.
5. North RB, et al. “Spinal Cord Stimulation versus Repeated Lumbosacral Spine Surgery for Chronic Pain.” Neurosurgery. 2005.
6. Waguespack A, et al. “Etiology of Failed Back Surgery Syndrome.” Pain Medicine. 2002;3(3):200–214.

Ready to explore non-surgical options for your back pain? Schedule your consultation with ValorSpine today.
Contact ValorSpine to schedule your consultation.